Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis)

GlaxoSmithKline462 enrolled

Overview

The purpose of this study is to collect and assess information on proper use of valaciclovir regarding safety and efficacy of long-term use in suppressive therapy for subjects with recurrent genital herpes.

Study Type

OBSERVATIONAL

Enrollment

462

Conditions

Genital Herpes

Interventions

Valaciclovir Hydrochloride.DRUG

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Subjects who started suppressive therapy for recurrent genital herpes for the first time Exclusion Criteria: * Subjects with a history of hypersensitivity to the ingredients of VALTREX or aciclovir

Outcomes

Primary Outcomes

The number of adverse events in Japanese subjects with recurrent genital herpes treated with valaciclovir

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.